Open Access

Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis

  • Authors:
    • Fabio D'Amico
    • Evangelia Skarmoutsou
    • Giuseppe Quaderno
    • Grazia Malaponte
    • Carmelo La Corte
    • Giuseppe Scibilia
    • Gabriella D'Agate
    • Paolo Scollo
    • Filippo Fraggetta
    • Demetrios A. Spandidos
    • Maria Clorinda Mazzarino
  • View Affiliations

  • Published online on: March 28, 2013     https://doi.org/10.3892/ijmm.2013.1325
  • Pages: 1011-1016
  • Copyright: © D'Amico et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In this study, we investigated the expression and localisation of the proteins, osteopontin (OPN) and prominin-1 (CD133), as well as the plasma OPN levels in the endometrium of patients with endometriosis. Samples of ectopic endometriotic lesions and normal endometrium were obtained from 31 women with endometriosis and 28 healthy control subjects. The mRNA and protein expression of OPN and CD133 was analysed by real‑time RT-PCR and immunohistochemistry. The plasma levels of OPN were determined by ELISA. Our results revealed that OPN mRNA and protein expression, as well as its release in the blood, was significantly increased in the endometriotic lesions in comparison to normal tissue. Although the presence of CD133+ cells was detected in the normal endometrium, as well as in the endometriosis specimens, a significant quantitative variation of this protein was not demonstrated in the patients with endometriosis. In conclusion, our data indicate that OPN is involved in the development of endometriosis by enhancing the invasiveness, proliferation and survival of endometrial cells in ectopic lesions. CD133 cannot be used as a disease marker for endometriosis, although an involvement of this protein in the pathogenesis of endometriosis cannot be excluded.
View Figures
View References

Related Articles

Journal Cover

May 2013
Volume 31 Issue 5

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
D'Amico F, Skarmoutsou E, Quaderno G, Malaponte G, La Corte C, Scibilia G, D'Agate G, Scollo P, Fraggetta F, Spandidos DA, Spandidos DA, et al: Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis. Int J Mol Med 31: 1011-1016, 2013
APA
D'Amico, F., Skarmoutsou, E., Quaderno, G., Malaponte, G., La Corte, C., Scibilia, G. ... Mazzarino, M.C. (2013). Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis. International Journal of Molecular Medicine, 31, 1011-1016. https://doi.org/10.3892/ijmm.2013.1325
MLA
D'Amico, F., Skarmoutsou, E., Quaderno, G., Malaponte, G., La Corte, C., Scibilia, G., D'Agate, G., Scollo, P., Fraggetta, F., Spandidos, D. A., Mazzarino, M. C."Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis". International Journal of Molecular Medicine 31.5 (2013): 1011-1016.
Chicago
D'Amico, F., Skarmoutsou, E., Quaderno, G., Malaponte, G., La Corte, C., Scibilia, G., D'Agate, G., Scollo, P., Fraggetta, F., Spandidos, D. A., Mazzarino, M. C."Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis". International Journal of Molecular Medicine 31, no. 5 (2013): 1011-1016. https://doi.org/10.3892/ijmm.2013.1325